Vivos Therapeutics (VVOS) Cash & Equivalents Growth (3y) (2022 - 2026)
Powered by 
Analysis
Vivos Therapeutics (VVOS) Cash & Equivalents Growth (3y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn | 5.02% |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn | 19.98% |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn | -6.78% |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn | -19.24% |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - | 50.92% |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn | -23.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -23.00% |
| Mar 31, 2026 | -33.10% |
| Dec 31, 2025 | -16.77% |
| Sep 30, 2025 | -22.73% |
| Jun 30, 2025 | -29.75% |
| Mar 31, 2025 | -49.17% |
| Dec 31, 2024 | -36.13% |
| Sep 30, 2024 | -39.53% |
| Jun 30, 2024 | -41.34% |
| Mar 31, 2024 | -42.94% |
| Dec 31, 2023 | -55.15% |
| Dec 31, 2022 | 95.72% |